methotrexate has been researched along with pretubulysin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baratti, E; Gorges, J; Kazmaier, U; Kern, S; Kuhn, J; Lächelt, U; Truebenbach, I; Wagner, E | 1 |
| Gorges, J; Höhn, M; Kazmaier, U; Kern, S; Truebenbach, I; Vollmar, AM; Wagner, E; Zahler, S | 1 |
| Gorges, J; Höhn, M; Kazmaier, U; Kern, S; Loy, DM; Truebenbach, I; Wagner, E | 1 |
3 other study(ies) available for methotrexate and pretubulysin
| Article | Year |
|---|---|
Sequence-Defined Oligoamide Drug Conjugates of Pretubulysin and Methotrexate for Folate Receptor Targeted Cancer Therapy.
Topics: Amides; Animals; Antineoplastic Agents; Biological Transport; Cell Line, Tumor; Drug Carriers; Folic Acid; Gene Expression; Humans; KB Cells; Ligands; Lymphocytes; Methotrexate; Mice; Mice, Nude; Molecular Targeted Therapy; Neoplasm Proteins; Oligopeptides; Polyethylene Glycols; Tetrahydrofolate Dehydrogenase; Tubulin Modulators; Xenograft Model Antitumor Assays | 2017 |
Combined antitumoral effects of pretubulysin and methotrexate.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Cycle; Cell Line, Tumor; Female; Humans; Leukemia L1210; Methotrexate; Mice; Mice, Nude; Neoplasms; Oligopeptides; Uterine Cervical Neoplasms | 2019 |
Combination Chemotherapy of L1210 Tumors in Mice with Pretubulysin and Methotrexate Lipo-Oligomer Nanoparticles.
Topics: Animals; Antimetabolites, Antineoplastic; Cell Cycle; Dynamic Light Scattering; Female; Leukemia L1210; Methotrexate; Mice; Mice, Nude; Microscopy, Electron, Transmission; Nanoparticles; Oligopeptides | 2019 |